Skip to main content
2024 DC-CSEM Conference Main banner

ALIYA A. KHAN, Clinical Professor of Medicine (she/her/hers)

Professor of Clinical Medicine
McMaster University
McMaster University
Oakville, Ontario, Canada

Aliya Khan, MD, FRCPC, FACP, FACE, FASBMR
Aliya Khan is a Clinical Professor of Medicine in the Division of Endocrinology and Geriatrics at McMaster University, Director of the Calcium Disorders Clinic, and Director of the Fellowship in Metabolic Bone Disease at McMaster University. She graduated from the University of Ottawa Medical School with honors. She trained in Internal Medicine, Geriatric Medicine and Endocrinology and also completed a fellowship in Metabolic Bone Disease at the University of Toronto. She has published over 200 scientific papers and numerous chapters and books on osteoporosis and parathyroid disease.
Dr. Khan chaired the development of global guidelines for parathyroid disease ,osteonecrosis of the jaw, new diagnostic criteria for hypophosphatasia , as well as treatment guidelines for X-linked hypophosphatemia in addition to Canadian guidelines for osteoporosis.
She is the principle investigator evaluating PTH and PTH analogues as well PTH1receptor agonists for the treatment of hypoparathyroidism including palopegteriparatide, natpar, eneboparatide as well as the calcilytic molecule encalaret for the treatment of autosomal dominant hypocalcemia.
She has received numerous national and international awards including the Queen’s Diamond Jubilee Medal for excellence, International Hypoparathyroidism Award, International Osteoporosis Foundation award for publishing excellence and recognized by Osteoporosis Canada for outstanding contributions to research and education. She is recognized as being in the top 0.1% of the world experts in hyperparathyroidism by Expertscape.

Presentation(s):